{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T12:26:54Z","timestamp":1708518414722},"reference-count":0,"publisher":"American Society for Clinical Investigation","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Invest."],"published-print":{"date-parts":[[1989,12,1]]},"DOI":"10.1172\/jci114360","type":"journal-article","created":{"date-parts":[[2008,2,28]],"date-time":"2008-02-28T21:19:53Z","timestamp":1204233593000},"page":"1762-1766","source":"Crossref","is-referenced-by-count":26,"title":["An arginine to glutamine mutation in residue 109 of human ornithine transcarbamylase completely abolishes enzymatic activity in Cos1 cells."],"prefix":"10.1172","volume":"84","author":[{"given":"J T","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R L","family":"Nussbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"232","container-title":["Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jci.org\/articles\/view\/114360\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T16:19:02Z","timestamp":1691079542000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jci.org\/articles\/view\/114360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,12,1]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1989,12,1]]}},"URL":"https:\/\/doi.org\/10.1172\/jci114360","relation":{},"ISSN":["0021-9738"],"issn-type":[{"value":"0021-9738","type":"print"}],"subject":[],"published":{"date-parts":[[1989,12,1]]}}}